Profile data is unavailable for this security.
About the company
Align Technology, Inc. is a global medical device company. The Company is engaged in the design, manufacture and marketing of Invisalign clear aligners, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for dental laboratories and dental practitioners. It operates through two segments: Clear Aligner, and Systems and Services. Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go and Invisalign Go Plus, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals during the course of treatment and consumer products that are complementary to its doctor-prescribed principal products. Its Systems and Services segment consists of its iTero intraoral scanning systems.
- Revenue in USD (TTM)3.99bn
- Net income in USD619.03m
- Incorporated1997
- Employees22.54k
- LocationAlign Technology Inc410 North Scottsdale Road, Suite 1300TEMPE 85281United StatesUSA
- Phone+1 (408) 738-1500
- Fax+1 (408) 470-1010
- Websitehttps://www.aligntech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Incorporated | 2.81bn | 509.89m | 11.69bn | 14.00k | 23.18 | 3.04 | 15.76 | 4.16 | 10.75 | 10.75 | 59.24 | 82.14 | 0.4071 | 2.53 | 6.77 | 200,601.60 | 7.39 | 5.57 | 8.05 | 6.10 | 54.93 | 55.22 | 18.16 | 13.90 | 1.43 | 12.19 | 0.3081 | 17.97 | 10.74 | 8.51 | 44.47 | 15.39 | 6.15 | 0.00 |
| ABIOMED, Inc. | 1.06bn | 217.58m | 12.81bn | 2.00k | 59.46 | 8.36 | 52.19 | 12.12 | 4.74 | 4.74 | 23.00 | 33.71 | 0.6681 | 2.19 | 11.75 | 527,367.40 | 13.76 | 16.91 | 14.96 | 18.75 | 81.48 | 82.13 | 20.60 | 23.45 | 6.86 | -- | 0.00 | 0.00 | 21.74 | 18.30 | -39.47 | 21.24 | -6.64 | -- |
| Cooper Companies Inc | 3.14bn | 948.00m | 16.07bn | 12.00k | 17.12 | 2.29 | 12.55 | 5.12 | 19.02 | 19.02 | 62.95 | 142.26 | 0.302 | 1.81 | 6.14 | 261,625.00 | 9.12 | 14.09 | 10.45 | 15.99 | 65.90 | 65.03 | 30.20 | 34.48 | 0.6882 | -- | 0.3168 | 0.3386 | 20.22 | 8.24 | 1,135.19 | 60.80 | 7.03 | 0.00 |
| Hologic, Inc. | 5.23bn | 1.51bn | 17.83bn | 6.71k | 12.03 | 3.56 | 9.13 | 3.41 | 5.94 | 5.94 | 20.54 | 20.03 | 0.5824 | 3.52 | 6.35 | 779,433.30 | 16.85 | 8.33 | 19.53 | 10.17 | 63.53 | 58.35 | 28.93 | 16.16 | 3.32 | 35.74 | 0.3627 | 0.00 | 49.14 | 14.74 | 67.82 | 41.42 | 10.56 | -- |
| Insulet Corporation | 1.18bn | 34.60m | 17.95bn | 2.30k | 542.92 | 42.49 | 188.78 | 15.24 | 0.4765 | 0.4765 | 16.74 | 6.09 | 0.5836 | 1.45 | 7.68 | 512,217.40 | 1.71 | 0.1989 | 1.95 | 0.2255 | 68.07 | 65.32 | 2.94 | 0.3174 | 3.54 | 2.48 | 0.7697 | 0.00 | 21.49 | 24.52 | 147.06 | -- | 40.87 | -- |
| Steris PLC | 4.77bn | 376.96m | 20.90bn | 16.42k | 55.86 | 3.26 | 21.24 | 4.38 | 3.74 | 3.74 | 47.37 | 64.02 | 0.4099 | 4.39 | 6.33 | 290,654.80 | 3.22 | 5.33 | 3.54 | 5.84 | 44.16 | 43.08 | 7.87 | 10.08 | 1.35 | 8.18 | 0.3183 | 39.11 | 47.55 | 11.90 | -38.63 | 17.27 | 10.71 | 9.17 |
| Align Technology, Inc. | 3.99bn | 619.03m | 21.37bn | 22.54k | 35.06 | 5.93 | 29.03 | 5.36 | 7.81 | 7.81 | 50.36 | 46.11 | 0.7121 | 4.47 | 4.59 | 177,008.70 | 11.05 | 25.12 | 16.07 | 36.50 | 72.60 | 73.40 | 15.52 | 30.36 | 1.15 | -- | 0.00 | 0.00 | 59.90 | 29.63 | -56.53 | 32.41 | 41.55 | -- |
| Zimmer Biomet Holdings Inc | 7.41bn | 299.60m | 23.60bn | 19.50k | 79.15 | 1.95 | 18.17 | 3.19 | 1.42 | 1.09 | 35.28 | 57.82 | 0.3243 | 0.9683 | 5.48 | 379,841.00 | 1.32 | 1.03 | 1.49 | 1.16 | 69.57 | 71.16 | 4.06 | 3.31 | 0.9499 | 7.03 | 0.3319 | 77.35 | 11.56 | 0.4339 | 400.00 | 7.13 | -1.88 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 685.60m | 24.40bn | 10.07k | 36.68 | 10.06 | 30.86 | 8.33 | 8.98 | 8.98 | 38.33 | 32.76 | 0.9304 | 4.58 | 5.81 | 290,968.70 | 21.17 | 14.11 | 25.35 | 16.78 | 40.87 | 35.61 | 22.75 | 16.01 | 2.41 | 128.80 | 0.0942 | 13.61 | 31.89 | 13.41 | 90.76 | 35.68 | 8.29 | 7.09 |
| Baxter International Inc | 14.19bn | 1.01bn | 29.69bn | 60.00k | 29.53 | 3.35 | 13.45 | 2.09 | 2.00 | 2.00 | 27.99 | 17.58 | 0.551 | 3.65 | 6.32 | 236,550.00 | 3.97 | 6.03 | 4.63 | 7.22 | 39.16 | 41.58 | 7.20 | 10.02 | 1.33 | 8.00 | 0.6521 | 38.31 | 9.52 | 4.70 | 16.52 | -23.70 | 0.6589 | 16.53 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2022 | 5.64m | 7.16% |
| Edgewood Management LLCas of 31 Mar 2022 | 4.37m | 5.55% |
| BlackRock Fund Advisorsas of 31 Mar 2022 | 3.60m | 4.57% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 3.08m | 3.91% |
| Janus Henderson Investors US LLCas of 31 Mar 2022 | 2.89m | 3.66% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2022 | 2.51m | 3.19% |
| AllianceBernstein LPas of 31 Mar 2022 | 2.47m | 3.13% |
| Sands Capital Management LLCas of 31 Mar 2022 | 2.36m | 3.00% |
| Polen Capital Management LLCas of 31 Mar 2022 | 1.87m | 2.38% |
| Wellington Management Co. LLPas of 31 Mar 2022 | 1.80m | 2.28% |
